Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
63.65
+1.62 (2.61%)
At close: Jun 26, 2026, 4:00 PM EDT
64.00
+0.35 (0.55%)
After-hours: Jun 26, 2026, 6:10 PM EDT
Nektar Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Nektar Therapeutics stock have an average target of 149.63, with a low estimate of 80 and a high estimate of 192. The average target predicts an increase of 135.08% from the current stock price of 63.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Nektar Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $76 → $151 | Buy | Maintains | $76 → $151 | +137.23% | May 14, 2026 |
| Wedbush | Wedbush | Hold Maintains $95 → $80 | Hold | Maintains | $95 → $80 | +25.69% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $185 | Buy | Maintains | $185 | +190.65% | May 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $140 | Buy | Maintains | $140 | +119.95% | May 8, 2026 |
| BTIG | BTIG | Buy Maintains $178 | Buy | Maintains | $178 | +179.65% | May 8, 2026 |
Financial Forecast
Revenue This Year
41.22M
from 55.23M
Decreased by -25.37%
Revenue Next Year
36.91M
from 41.22M
Decreased by -10.46%
EPS This Year
-9.54
from -8.66
EPS Next Year
-12.56
from -9.54
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 44.8M | 45.7M | |
| Avg | 41.2M | 36.9M | |
| Low | 24.0M | 8.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -19.0% | 10.8% | |
| Avg | -25.4% | -10.5% | |
| Low | -56.5% | -80.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -7.62 | -10.18 | |
| Avg | -9.54 | -12.56 | |
| Low | -11.02 | -14.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.